Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Daniel Merritt Bowles"'
Autor:
Angela Wolford, Heather Eng, Yanwei Zhang, Suvi T. M. Orr, Kay Ahn, Daniel W. Widlicka, Carlin Okerberg, Amit S. Kalgutkar, Yingmei Qi, Samantha N. Spath, Paul D. Bonin, Dilinie P. Fernando, Aaron C. Smith, Tim F. Ryder, Karen Walters, Yan Zhang, David Hepworth, Wenhua Jiao, Joseph S. Warmus, Benjamin N. Rocke, Tristan S. Maurer, Daniel Merritt Bowles, Daniel W. Kung, Scott W. Bagley, Philip A. Carpino, Roger B. Ruggeri, Gang Xing, Leonard Buckbinder, Edward L. Conn, Matthew S. Dowling, Raman Sharma
Publikováno v:
Journal of Medicinal Chemistry. 58:8513-8528
Myeloperoxidase (MPO) is a heme peroxidase that catalyzes the production of hypochlorous acid. Clinical evidence suggests a causal role for MPO in various autoimmune and inflammatory disorders including vasculitis and cardiovascular and Parkinson's d
Publikováno v:
Synthetic Communications. 42:1855-1863
Air oxidation of N-cyclopropylanilines was shown to occur under either ambient conditions or accelerated conditions (warming or shining light) in an open container. A subsequent fragmentation resulted in formation of the corresponding acetamide. Whil
Autor:
Xiangyang Chen, E. Jason Kiser, David W. Piotrowski, Robert A. Wade, Cuiman Cai, Matthew F. Sammons, Catherine Angela Hulford, Daniel Merritt Bowles, Sandra M. Jennings, Agustin Casimiro-Garcia, Charles Boos
Publikováno v:
Tetrahedron Letters. 52:7025-7029
The large scale synthesis of functionalized 2-pyridylboronate 8 and optimization of its Suzuki–Miyaura coupling to chloropyrazoline (R)-7 to provide a scalable synthesis of mineralocorticoid antagonist (R)-1 is described.
Autor:
Kevin K.-C. Liu, Qinhua Huang, Paul F. Richardson, Jinjiang Zhu, Graham L. Smith, Daniel Merritt Bowles, Neal W. Sach
Publikováno v:
Organic Process Research & Development. 15:556-564
On the basis of a more practical and scalable route to an iodothiophene, an efficient and reliable synthesis has been developed for three selective PI3K inhibitors. From this advanced intermediate, the three title compounds were each prepared in five
Autor:
David C. Boyles, Stephanie Schuyler, Edward J. Hessler, Jeffrey A. Pfefferkorn, Daniel Merritt Bowles, Chulho Choi
Publikováno v:
Organic Process Research & Development. 15:148-157
Early process development work toward a promising pyrazole-based HMG-CoA reductase inhibitor is described. PF-03052334-02 (1) was prepared in 14 synthetic steps with a 21% overall yield, highlighted by a modified three-step hydroxypyrazole formation
Autor:
Daniel Merritt Bowles, David C. Schineman, Markus Tamm, Kurtis G. Ritsema, Jonathan Mark Miller, William Keun Chan Park, David C. Boyles, Scott D. Larsen, Richard H. Hutchings, Timothy T. Curran, Gary Louis Bolton
Publikováno v:
Organic Process Research & Development. 12:1183-1187
Development work toward an enabling synthesis of preparative scale batches of an imidazole-based HMG-CoA reductase inhibitor is described. The desired target was synthesized in 16% yield over 7 steps, highlighted by an imidazole-forming condensation
Publikováno v:
ChemInform. 43
Compounds (I) decompose to (II) and (III) even when exposed to light of the laboratory and air.
Autor:
Erasga Noe Ouano, David C. Boyles, Chitase Lee, Vaishali Sahasrabudhe, Emi Kimoto, Mark C. Kowala, Yurong Lai, Jonathan Chupka, Bharat K. Trivedi, Xue-Min Cheng, Jeffrey C. Hanselman, Valerie Askew, Zhiwu Lin, P. L. Barclay, Bruce Auerbach, David B. Duignan, Jeffrey A. Pfefferkorn, Theunis C. Goosen, Bo Feng, Lisa Dillon, Richard H. Hutchings, Andrew Robertson, Robert M. Kennedy, Bradley D. Tait, Ayman El-Kattan, Scott D. Larsen, Gina Lu, Daniel Merritt Bowles, Vu Le, Mark Milad, Erick Kindt, Karl Olsen, Mark Richard Bush, John Litchfield, Carine Boustany, Rebecca Bakker-Arkema, Renato J. Scialis, Yi An Bi, Catherine Sekerke, Jaap Mandema, Karen Atkinson
Publikováno v:
Bioorganicmedicinal chemistry letters. 21(9)
The design of drugs with selective tissue distribution can be an effective strategy for enhancing efficacy and safety, but understanding the translation of preclinical tissue distribution data to the clinic remains an important challenge. As part of
Autor:
Steven R. Miller, Scott D. Larsen, Yuntao Song, David C. Boyles, Jeffrey A. Pfefferkorn, Chulho Choi, William Kissel, Bharat K. Trivedi, Daniel Merritt Bowles, Kuai Lin Sun
Publikováno v:
ChemInform. 38
This paper describes the development of an efficient and scalable second generation synthesis of novel, pyrrole-based HMG-CoA reductase inhibitors. Compound 1 was identified as part of a discovery program aimed at finding improved treatments for hype